SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

GD Song, Y Sun, H Shen, W Li - Tumor Biology, 2015 - Springer
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …
被引用次数：74 相关文章

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

GD Song, Y Sun, H Shen, W Li - Tumour biology: the …, 2015 - pubmed.ncbi.nlm.nih.gov
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

GD Song, Y Sun, H Shen, W Li - Tumor Biology, 2015 - infona.pl
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

G Song, Y Sun, H Shen, W Li - Tumor Biology, 2015 - search.proquest.com
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.

GD Song, Y Sun, H Shen, W Li - Tumour Biology: the Journal of the …, 2015 - europepmc.org
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …

[引用][C] SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

GD Song, Y Sun, H Shen, W Li - Tumor biology, 2015 - Springer